Related Experiment Video
Updated: Feb 10, 2026

The Multiple Sclerosis Performance Test MSPT: An iPad-Based Disability Assessment Tool
Published on: June 30, 2014
Infectious exposure, antibiotic use, and multiple sclerosis: A population-based incident case-control study
I Abdollahpour1, S Nedjat2, M A Mansournia3
1Department of Epidemiology, School of Public Health, Arak University of Medical Sciences, Arak, Iran.
Background:
The existing reports regarding the potential role of infections as well as antibiotic use in multiple sclerosis (MS) etiology are inconclusive.
Objectives:
We aimed to investigate the association of viral infections as well as antibiotic use and the risk of developing MS.
Materials & Methods:
This was a population-based incident case-control study of 547 incident cases and 1057 general population controls obtained from 22 municipality areas of Tehran (7/8/2013-17/2/2015). Multiple logistic regression models were used to determine the adjusted associations.
Results:
Overall antibiotic use for ≥14 days during 3 years before the index date, significantly decreased the odds of MS OR 0.69 (95%CI: 0.53-0.91, P = .008). The results were consistent for different types of antibiotics, including penicillin OR 0.50 (95%CI: 0.34-0.75, P = .001) and cephalosporins OR 0.25 (95%CI: 0.12-0.50, P < .001). History of IM was associated with a more than 5fold increased risk of MS OR = 5.7 (95%CI, 1.28-25.37). There was no statistically significant association between any other single or cumulative number of viral infections with subsequent risk of MS (P > .05).
Conclusions:
Considering the possibility of reverse causation, the results of this large case-control study suggest that use of antibiotics may be associated with a decreased risk of MS. However, viral disease other than infectious mononucleosis was not associated with MS risk.
Insights
Antibiotic use, particularly penicillin and cephalosporins, may decrease the risk of developing multiple sclerosis (MS). However, most viral infections, except infectious mononucleosis, showed no significant association with MS risk.
Area of Science:
- Neurology
- Epidemiology
- Infectious Diseases
Background:
- Inconclusive evidence exists regarding the role of infections and antibiotic use in multiple sclerosis (MS) etiology.
- Understanding potential environmental triggers for MS is crucial for prevention and treatment strategies.
Purpose of the Study:
- To investigate the association between viral infections, antibiotic use, and the risk of developing multiple sclerosis.
- To clarify the relationship between specific infections and antibiotic classes with MS development.
Main Methods:
- A population-based incident case-control study was conducted.
- Data included 547 incident MS cases and 1057 general population controls from Tehran.
- Multiple logistic regression models were employed to analyze adjusted associations.
Main Results:
- Antibiotic use for ≥14 days within 3 years prior to the index date was associated with a significantly decreased odds of MS (OR 0.69).
- Specific antibiotics like penicillin (OR 0.50) and cephalosporins (OR 0.25) showed a significant reduction in MS risk.
- A history of infectious mononucleosis (IM) was linked to a more than fivefold increased risk of MS (OR 5.7).
- No significant association was found between other viral infections and MS risk.
Conclusions:
- Antibiotic use may be associated with a reduced risk of multiple sclerosis, though reverse causation is a possibility.
- Viral infections, with the exception of infectious mononucleosis, do not appear to be significantly associated with an increased risk of MS.
Related Concept Videos
Prevalence and Incidence
Prevalence indicates the proportion of individuals in a population who have a specific disease or health...
Antibiotic Selection
What is Population Genetics?
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Bioavailability Study Design: Single Versus Multiple Dose Studies
What are Populations and Communities?

